Inovio Pharmaceuticals Inc (INO)
4.07
+0.01
(+0.25%)
USD |
NASDAQ |
Nov 22, 16:00
4.08
+0.01
(+0.25%)
After-Hours: 20:00
Inovio Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.832M |
| September 30, 2023 | 0.854M |
| June 30, 2023 | 9.620M |
| March 31, 2023 | 10.18M |
| December 31, 2022 | 10.26M |
| September 30, 2022 | 10.98M |
| June 30, 2022 | 2.114M |
| March 31, 2022 | 1.603M |
| December 31, 2021 | 1.775M |
| September 30, 2021 | 6.516M |
| June 30, 2021 | 6.461M |
| March 31, 2021 | 6.455M |
| December 31, 2020 | 7.411M |
| September 30, 2020 | 2.110M |
| June 30, 2020 | 2.741M |
| March 31, 2020 | 2.609M |
| December 31, 2019 | 4.112M |
| September 30, 2019 | 6.335M |
| June 30, 2019 | 7.469M |
| March 31, 2019 | 31.78M |
| December 31, 2018 | 30.48M |
| September 30, 2018 | 36.77M |
| June 30, 2018 | 37.41M |
| March 31, 2018 | 33.37M |
| December 31, 2017 | 42.22M |
| Date | Value |
|---|---|
| September 30, 2017 | 41.95M |
| June 30, 2017 | 51.84M |
| March 31, 2017 | 37.63M |
| December 31, 2016 | 35.37M |
| September 30, 2016 | 32.79M |
| June 30, 2016 | 44.43M |
| March 31, 2016 | 43.52M |
| December 31, 2015 | 40.57M |
| September 30, 2015 | 37.09M |
| June 30, 2015 | 14.75M |
| March 31, 2015 | 13.27M |
| December 31, 2014 | 10.46M |
| September 30, 2014 | 9.739M |
| June 30, 2014 | 17.39M |
| March 31, 2014 | 14.37M |
| December 31, 2013 | 13.47M |
| September 30, 2013 | 12.86M |
| June 30, 2013 | 4.230M |
| March 31, 2013 | 3.881M |
| December 31, 2012 | 4.119M |
| September 30, 2012 | 4.617M |
| June 30, 2012 | 6.399M |
| March 31, 2012 | 8.383M |
| December 31, 2011 | 9.795M |
| September 30, 2011 | 10.52M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.832M
Minimum
Dec 2023
10.98M
Maximum
Sep 2022
5.096M
Average
4.112M
Median
Dec 2019
Revenue (TTM) Benchmarks
| Novavax Inc | 847.25M |
| Baxter International Inc | 17.28B |
| AIM ImmunoTech Inc | 0.19M |
| Protalix BioTherapeutics Inc | 45.67M |
| Armata Pharmaceuticals Inc | -- |